deluge said:
timebomb85 said:
Roughly 4 months on Tirzepatide so far, and it has genuinely reshaped my life. Few things
I've ever changed have matched the expectation I carried into it. Lately I've been reading obsessively
about the rest of the peptide catalogue, trying to work out whether they land with comparable force for
the people taking them. So I'd like to hear: has any peptide hit you that hard? Do returns shrink once
you start layering more in? Is Tirzepatide simply exceptional as a compound? Or am I an unusually
strong responder while others find it mediocre? I'm just nosy about how it's gone for everyone else.
Having worked through 7 different peptides, my verdict is that Tirz stands head and shoulders above all
of them.
The weight Tirz took off appears to have slashed inflammation and joint pain, and my plantar fasciitis
disappeared entirely. (Could be the compound itself, could be losing 40 lbs).
GHK-Cu certainly improved how resilient, supple and textured my skin became, though nothing on the
scale of what Tirz did for weight. Turkey neck and wrinkles barely shifted, honestly. Marginal gains,
I'd say. I pair it with dissolved collagen, micro needling, and a GHK-Cu 4% topical three times a week.
BPC-157 and TB-500, I believe, bought me more ground on joint pain and inflammation — though perhaps
20% better rather than Tirz' 60%? I'm not attempting to heal a break or tear; maybe those respond far
better?
Reta, layered in, seems to be slowly taking me lower from my 20% bodyweight reduction (BMI 40 down to
30). The scale of change Tirz produced isn't there, though.
Cagri stacked on top also appears to assist further loss. Again nothing dramatic — incremental.
VIP — the rush that arrives minutes after pinning is wonderful! I've been at 266mcg/Daily. It's like a
mug of coffee when you're called out at 2am for work; you can feel it moving through your veins. People
don't think Angiogenesis be like it is, but it do! (Rumour has it the downside is that any tumor you
have will be fed too. Might end up regretting that one).